287 filings
Page 11 of 15
6-K
iky ayr0j1a7ukqa
3 May 07
Ym Biosciences Reports Aerolef™ Randomized Phase Iib Trial Meets Primary Endpoint In Patients with Post-surgical Pain
12:00am
6-K
sczw248ihau9md
17 Apr 07
Ym Biosciences’ Partner Daiichi Sankyo Receives
12:00am
6-K
73sngtm060xm7lsui2
4 Apr 07
Current report (foreign)
12:00am
6-K
6tq09vhh 8k1l6jdld
6 Mar 07
Ym Biosciences Completes Enrolment of Aerolef™ Phase Iib Pain Trial
12:00am
6-K
hrxbn0v4e
13 Feb 07
Current report (foreign)
12:00am
6-K
vu5phwv 6gpi3
12 Feb 07
Current report (foreign)
12:00am
6-K
4tic htlbw4
12 Feb 07
Ym Biosciences Reports Second Quarter 2007
12:00am
6-K
5dr40j
12 Feb 07
Ym Biosciences Announces Management Changes
12:00am
6-K
hmyl5q9sb
31 Jan 07
Ym Biosciences Announces Termination of the Tesmilifene Phase Iii Pivotal Trial In Advanced Breast Cancer
12:00am
6-K
9mldvd m7
31 Jan 07
Current report (foreign)
12:00am
6-K
c42 qclymxw6dh
16 Jan 07
Ym Biosciences Provides Update on Tesmilifene Pivotal Trial
12:00am
6-K
z1m druksb3
21 Dec 06
Ym Biosciences Partners with Tty Biopharm to Develop Tesmilifene In Taiwan
12:00am
6-K
gb20b34
13 Nov 06
Ym Biosciences Reports First Quarter 2007
12:00am
6-K
6z9z mf0etmb
13 Nov 06
Current report (foreign)
12:00am
6-K
4rtdsn
1 Nov 06
Annual and Special Meeting
12:00am
6-K
tb9mey3o
18 Oct 06
Ym Biosciences Announces Results of Aerolef™ Phase
12:00am
6-K
d8qofyxfb2aqyhp30
27 Sep 06
Ym Biosciences Announces Aerolef™ Phase Iib Interim Review
12:00am
6-K
g697w5du1eyvxd6eumuf
25 Sep 06
Ym Biosciences Receives Clearance to Import Nimotuzumab for Clinical Research In the Us
12:00am
6-K
2rxrg036 2dx0zis
22 Sep 06
Ym Biosciences Reports 2006 Year End Operational and Financial Results
12:00am
6-K
idl m41s243qzd88
24 Aug 06
Ym Biosciences Announces Independent Data Safety Monitoring Board Recommends Tesmilifene Pivotal Trial Continue As Planned
12:00am